Pharmacokinetics of a single oral dose of vitamin D3 (70,000 IU) in pregnant and non-pregnant women
Daniel E Roth, Abdullah Al Mahmud, Rubhana Raqib, Robert E Black, Abdullah H Baqui, Daniel E Roth, Abdullah Al Mahmud, Rubhana Raqib, Robert E Black, Abdullah H Baqui
Abstract
Background: Improvements in antenatal vitamin D status may have maternal-infant health benefits. To inform the design of prenatal vitamin D3 trials, we conducted a pharmacokinetic study of single-dose vitamin D3 supplementation in women of reproductive age.
Methods: A single oral vitamin D3 dose (70,000 IU) was administered to 34 non-pregnant and 27 pregnant women (27 to 30 weeks gestation) enrolled in Dhaka, Bangladesh (23°N). The primary pharmacokinetic outcome measure was the change in serum 25-hydroxyvitamin D concentration over time, estimated using model-independent pharmacokinetic parameters.
Results: Baseline mean serum 25-hydroxyvitamin D concentration was 54 nmol/L (95% CI 47, 62) in non-pregnant participants and 39 nmol/L (95% CI 34, 45) in pregnant women. Mean peak rise in serum 25-hydroxyvitamin D concentration above baseline was similar in non-pregnant and pregnant women (28 nmol/L and 32 nmol/L, respectively). However, the rate of rise was slightly slower in pregnant women (i.e., lower 25-hydroxyvitamin D on day 2 and higher 25-hydroxyvitamin D on day 21 versus non-pregnant participants). Overall, average 25-hydroxyvitamin D concentration was 19 nmol/L above baseline during the first month. Supplementation did not induce hypercalcemia, and there were no supplement-related adverse events.
Conclusions: The response to a single 70,000 IU dose of vitamin D3 was similar in pregnant and non-pregnant women in Dhaka and consistent with previous studies in non-pregnant adults. These preliminary data support the further investigation of antenatal vitamin D3 regimens involving doses of ≤70,000 IU in regions where maternal-infant vitamin D deficiency is common.
Trial registration: ClinicalTrials.gov NCT00938600.
Figures
References
- Ross AC, Taylor CL, Yaktine AL, Del Valle HB. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press; 2010.
- ACOG Committee Opinion No. 495. Vitamin D: screening and supplementation during pregnancy. Obstet Gynecol. 2011;118:197–198. doi: 10.1097/AOG.0b013e318227f06b.
- Specker BL. Does vitamin D during pregnancy impact offspring growth and bone? Proc Nutr Soc. 2011;FirstView:1–8.
- Roth DE. Vitamin D, supplementation during pregnancy: safety considerations in the design and interpretation of clinical trials. J Perinatol. 2011;31:449–459. doi: 10.1038/jp.2010.203.
- Sahu M, Das V, Aggarwal A, Rawat V, Saxena P, Bhatia V. Vitamin D replacement in pregnant women in rural north India: a pilot study. Eur J Clin Nutr. 2009;63:1157–1159. doi: 10.1038/ejcn.2009.27.
- Zeghoud F, Garabedian M, Jardel A, Bernard N, Melchior J. Administration of a single dose of 100,000 U.I. of vitamin D3 in the pregnant woman in winter. The effect on blood calcium level of the newborn infant. J Gynecol Obstet Biol Reprod (Paris) 1988;17:1099–1105.
- Marwahaa RK, Tandona N, Chopraa S, Agarwala NM, Garga K, Sharmaa B, Kanwara RS, Bhadraa K, Singha S. et al.Vitamin D status in pregnant Indian women across trimesters and different seasons and its correlation with neonatal serum 25-hydroxyvitamin D levels. Br J Nutr. 2011;106:1383–1389. doi: 10.1017/S000711451100170X.
- Roth DE, Shah MR, Black RE, Baqui AH. Vitamin D status of infants in northeastern rural bangladesh: preliminary observations and a review of potential determinants. J Health Popul Nutr. 2010;28:458–469.
- Seamans KM, Cashman KD. Existing and potentially novel functional markers of vitamin D status: a systematic review. Am J Clin Nutr. 2009;89:1997S–2008S. doi: 10.3945/ajcn.2009.27230D.
- Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004;89:5387–5391. doi: 10.1210/jc.2004-0360.
- Ilahi M, Armas LA, Heaney RP. Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr. 2008;87:688–691.
- Maalouf J, Nabulsi M, Vieth R, Kimball S, El-Rassi R, Mahfoud Z, El-Hajj Fuleihan G. Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children. J Clin Endocrinol Metab. 2008;93:2693–2701. doi: 10.1210/jc.2007-2530.
- Wagner D, Hanwell HE, Vieth R. An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem. 2009;42:1549–1556. doi: 10.1016/j.clinbiochem.2009.07.013.
- Carter GD, Berry JL, Gunter E, Jones G, Jones JC, Makin HL, Sufi S, Wheeler MJ. Proficiency testing of 25-hydroxyvitamin D (25-OHD) assays. J Steroid Biochem Mol Biol. 2010;121:176–179. doi: 10.1016/j.jsbmb.2010.03.033.
- Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington: National Academy Press; 1997. Food and Nutrition Board IOM.
- Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001;73:288–294.
- Gordon AY, Salzman P. Optimality of the Holm procedure among general step-down multiple testing procedures. Stat Probability Lett. 2008;78:1878–1884. doi: 10.1016/j.spl.2008.01.055.
- Payne RB, Little AJ, Evans RT. Albumin-adjusted calcium concentration in serum increases during normal pregnancy. Clin Chem. 1990;36:142–144.
- Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D’Erasmo E, Carnevale V, Scillitani A, Minisola S. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab. 2008;93:3015–3020. doi: 10.1210/jc.2008-0350.
- Cipriani C, Romagnoli E, Scillitani A, Chiodini I, Clerico R, Carnevale V, Mascia ML, Battista C, Viti R. et al.Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study. J Clin Endocrinol Metabol. 2010;95:4771–4777. doi: 10.1210/jc.2010-0502.
- Bacon CJ, Gamble GD, Horne AM, Scott MA, Reid IR. High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int. 2009;20:1407–1415. doi: 10.1007/s00198-008-0814-9.
- Weisman Y, Schen RJ, Eisenberg Z, Amarilio N, Graff E, Edelstein-Singer M, Goldray D, Harell A. Single oral high-dose vitamin D3 prophylaxis in the elderly. J Am Geriatr Soc. 1986;34:515–518.
- Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;303:1815–1822. doi: 10.1001/jama.2010.594.
- Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: Double blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res. 2011;26:2341–2357. doi: 10.1002/jbmr.463.
- Vähävihu K, Ylianttila L, Kautiainen H, Viljakainen H, Lamberg-Allardt C, Hasan T, Tuohimaa P, Reunala T, Snellman E. Narrowband ultraviolet B course improves vitamin D balance in women in winter. Br J Dermatol. 2010;162:848–853.
- Bouillon R, Van Assche FA, Van Baelen H, Heyns W, De Moor P. Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest. 1981;67:589–596. doi: 10.1172/JCI110072.
- Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J. Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest. 1993;91:2552–2555. doi: 10.1172/JCI116492.
- Heaney RP. Vitamin D, and calcium interactions: functional outcomes. Am J Clin Nutr. 2008;88:541S–544S.
- Vieth R. How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res. 2009;29:3675–3684.
Source: PubMed